CAS
CTV

CTC Alternative Strategies’s Innovid Corp. CTV Stock Holding History

CTC Alternative Strategies’s Portfolio CTV Stock Details CTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,473
Closed -$60.9K – 289
2024
Q1 		$60.9K Buy
+24,473
New +$42.3K 0.04% 100

Other funds holding CTV

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CTC Alternative Strategies's CTV Position: Q2 2024 in Review

CTC Alternative Strategies sold out of Innovid Corp. (CTV) in Q2 2024, closing a stake of 24,473 shares — an estimated $60.9K sold.

CTC Alternative Strategies first reported a position in CTV in Q1 2024 and held it in 1 quarter. The position peaked at $60.9K in Q1 2024. 74 funds tracked by Wall St. Rank hold CTV as of Q2 2024.

  • CTC Alternative Strategies reported no remaining Innovid Corp. position as of Q2 2024 after selling out during the quarter.
  • CTC Alternative Strategies sold 24,473 Innovid Corp. shares in Q2 2024, an estimated $60.9K.
  • CTC Alternative Strategies first reported a position in Innovid Corp. in Q1 2024 and held it in 1 quarter.
  • CTC Alternative Strategies's Innovid Corp. position peaked at $60.9K in Q1 2024.
  • 74 funds tracked by Wall St. Rank held Innovid Corp. as of Q2 2024.

Based on CTC Alternative Strategies's 13F filing for Q2 2024, filed 2 Aug 2024.